These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38365828)

  • 1. Administration of methylene blue in septic shock: pros and cons.
    Arias-Ortiz J; Vincent JL
    Crit Care; 2024 Feb; 28(1):46. PubMed ID: 38365828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressor-Sparing Action of Methylene Blue in Severe Sepsis and Shock: A Narrative Review.
    Puntillo F; Giglio M; Pasqualucci A; Brienza N; Paladini A; Varrassi G
    Adv Ther; 2020 Sep; 37(9):3692-3706. PubMed ID: 32705530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Story of Nitric Oxide, Sepsis and Methylene Blue: A Comprehensive Pathophysiologic Review.
    Saha BK; Burns SL
    Am J Med Sci; 2020 Oct; 360(4):329-337. PubMed ID: 32631574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal strategy to counteract vasodilation in septic shock.
    Leone M; Einav S; Antonucci E; Depret F; Lakbar I; Martin-Loeches I; Wieruszewski PM; Myatra SN; Khanna AK
    Anaesth Crit Care Pain Med; 2023 Jun; 42(3):101193. PubMed ID: 36621622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylene blue for the treatment of septic shock.
    Paciullo CA; McMahon Horner D; Hatton KW; Flynn JD
    Pharmacotherapy; 2010 Jul; 30(7):702-15. PubMed ID: 20575634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of methylene blue on hemodynamic response in the early phase of septic shock: A case series.
    Luis-Silva F; Menegueti MG; Sato L; Peres LM; Dos Reis Sepeda C; Petroski-Moraes BC; Donadel MD; Gallo GB; Jordani MC; Mestriner F; Becari C; Basile-Filho A; Evora PRB; Martins-Filho OA; Auxiliadora-Martins M
    Medicine (Baltimore); 2023 Jan; 102(4):e32743. PubMed ID: 36705345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressor Therapy in the Intensive Care Unit.
    Russell JA; Gordon AC; Williams MD; Boyd JH; Walley KR; Kissoon N
    Semin Respir Crit Care Med; 2021 Feb; 42(1):59-77. PubMed ID: 32820475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of midodrine and methylene blue as catecholamine-sparing agents in intensive care unit patients with shock.
    Tchen S; Sullivan JB
    J Crit Care; 2020 Jun; 57():148-156. PubMed ID: 32145658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of iNOS/sGC/PKG pathway, COX-2, CYP4A1, and gp91(phox) to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against vasodilation, hypotension, tachycardia, and inflammation in a rat model of septic shock.
    Tunctan B; Korkmaz B; Sari AN; Kacan M; Unsal D; Serin MS; Buharalioglu CK; Sahan-Firat S; Cuez T; Schunck WH; Manthati VL; Falck JR; Malik KU
    Nitric Oxide; 2013 Sep; 33():18-41. PubMed ID: 23684565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of methylene blue on refractory neonatal hypotension.
    Driscoll W; Thurin S; Carrion V; Steinhorn RH; Morin FC
    J Pediatr; 1996 Dec; 129(6):904-8. PubMed ID: 8969734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does methylene blue administration to septic shock patients affect vascular permeability and blood volume?
    Donati A; Conti G; Loggi S; Münch C; Coltrinari R; Pelaia P; Pietropaoli P; Preiser JC
    Crit Care Med; 2002 Oct; 30(10):2271-7. PubMed ID: 12394955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of methylene blue in human septic shock: renaissance of an old drug?
    Evgenov OV; Bjertnaes LJ
    Crit Care Med; 2003 May; 31(5):1601-2; author reply 1602. PubMed ID: 12771654
    [No Abstract]   [Full Text] [Related]  

  • 13. Methylene blue administration in septic shock: a clinical trial.
    Preiser JC; Lejeune P; Roman A; Carlier E; De Backer D; Leeman M; Kahn RJ; Vincent JL
    Crit Care Med; 1995 Feb; 23(2):259-64. PubMed ID: 7532559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylene blue reverses endotoxin-induced hypotension.
    Keaney JF; Puyana JC; Francis S; Loscalzo JF; Stamler JS; Loscalzo J
    Circ Res; 1994 Jun; 74(6):1121-5. PubMed ID: 8187278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of methylene blue on hemodynamic and metabolic response in septic shock patients.
    Luis-Silva F; Menegueti MG; Sepeda CDR; Petroski-Moraes BC; Sato L; Peres LM; Becari C; Basile-Filho A; Evora PRB; Martins-Filho OA; Auxiliadora-Martins M
    Medicine (Baltimore); 2022 Jan; 101(3):e28599. PubMed ID: 35060528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of methylene blue in refractory septic shock: study protocol for a multicenter, randomized, placebo-controlled trial.
    Jia J; Ji J; Liu Z
    Trials; 2024 Sep; 25(1):630. PubMed ID: 39334256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressors to treat refractory septic shock.
    Meresse Z; Medam S; Mathieu C; Duclos G; Vincent JL; Leone M
    Minerva Anestesiol; 2020 May; 86(5):537-545. PubMed ID: 31994366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-conventional vasopressors in septic shock: effects on hepatosplanchnic blood flow.
    Takala J
    Schweiz Med Wochenschr; 2000 Dec; 130(50):1937-41. PubMed ID: 11189439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressor therapy in critically ill patients with shock.
    Russell JA
    Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of the action of nitric oxide in human septic shock increases systemic vascular resistance and has detrimental effects on pulmonary function after a short infusion of methylene blue.
    Weingartner R; Oliveira E; Oliveira ES; Sant'Anna UL; Oliveira RP; Azambuja LA; Friedman G
    Braz J Med Biol Res; 1999 Dec; 32(12):1505-13. PubMed ID: 10585632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.